Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAAS Inhibition and Spironolactone for Post-operative Atrial Fibrillation
NCT00141778Phase 3Completed
- Sponsor
- Vanderbilt University
- Start
- Apr 2005
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ramipril and spironolactone in Atrial fibrillation (AFib), sponsored by Vanderbilt University. Started Apr 2005; status: completed.
02
Drugs
ramiprilspironolactone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00141778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141778.